Knockdown of IGHG1 reduced the expression and the activity of FECH protein, an enzyme involved in heme biosynthesis, in HT29 cells (Figure 4a and b), which indicated that IGHG1 contributed to FECH activation in colorectal cancer. The gene discussed is FECH; the disease is colorectal cancer.